Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ahed Makhoul

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Cleveland Clinic Journal of Medicine|May 31, 2020
The role of palliative care in COVID-19Denise Sese, Ahed Makhoul, Laura Hoeksema, et al.
The American Journal of Hospice & Palliative Care|March 24, 2025
Do Automated Reminders Decrease No-Show Visits in an Outpatient Palliative Medicine Clinic?Ruth L Lagman, Renato V Samala, Ahed Makhoul, et al.
The American Journal of Hospice & Palliative Care|December 24, 2022
Response Rates to Methylnaltrexone in Hospitalized Cancer PatientsDavid Harris, David Kalir, Cory Chevalier, et al.
Leukemia & Lymphoma|January 9, 2019
<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomesNour Abuhadra, Sudipto Mukherjee, Karam Al-Issa, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Cleveland Clinic Journal of Medicine|May 31, 2020
The role of palliative care in COVID-19Denise Sese, Ahed Makhoul, Laura Hoeksema, et al.
The American Journal of Hospice & Palliative Care|March 24, 2025
Do Automated Reminders Decrease No-Show Visits in an Outpatient Palliative Medicine Clinic?Ruth L Lagman, Renato V Samala, Ahed Makhoul, et al.
The American Journal of Hospice & Palliative Care|December 24, 2022
Response Rates to Methylnaltrexone in Hospitalized Cancer PatientsDavid Harris, David Kalir, Cory Chevalier, et al.
Leukemia & Lymphoma|January 9, 2019
<i>BCOR</i> and <i>BCORL1</i> mutations in myelodysplastic syndromes (MDS): clonal architecture and impact on outcomesNour Abuhadra, Sudipto Mukherjee, Karam Al-Issa, et al.
Pageof 1